FDA Grants Approval for Aciclovir ANDA215669 by Hetero Labs
The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 215669 for aciclovir submitted by Hetero Labs.
Asset / Drug
Drug and asset intelligence for Aciclovir with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Aurobindo Pharma USA has submitted a supplement application for Aciclovir (ANDA075211) which is currently under standard review by the FDA.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.